NEW DELHI: China is preparing to give swift regulatory approvals to India-manufactured drugs, the head of an Indian export promotion group said, as Beijing looks for new commercial partners ahead of what could be a protracted trade war with the United States.
Indian firms are looking to fill gaps in Chinese demand for generic drugs, software, sugar NSE 0.00 % and some varieties of rice, trade officials in New Delhi said.
“We do feel that China is receptive at this time and it’s all about making prices competitive,” said a government official involved in the effort to promote trade with China. The official declined to be identified since he is not authorised to speak to the media.